| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $530M | $386M | — | 37.3% | — |
| Op. Income | $225M | $83M | — | 170.3% | — |
| Gross Margin | 46.2% | 47.4% | — | -1.2pp | — |
| Net Margin | 34.8% | 17.0% | — | 17.8pp | — |
| EPS (Diluted) | $0.84 | $0.31 | — | 171.0% | — |
| Free Cash Flow | $108M | -$2M | — | 4603.6% | — |
| Item | Amount |
|---|---|
| REVENUE | $530M |
| Cost of Revenue | $285M |
| GROSS PROFIT | $245M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $17M |
| Other Expenses | $2M |
| Operating Expenses | $19M |
| Cost & Expenses | $304M |
| OPERATING INCOME | $225M |
| Interest Income | $4M |
| Interest Expense | $4M |
| Other Income/Expenses | -$16M |
| INCOME BEFORE TAX | $210M |
| Income Tax Expense | $36M |
| Net Income from Continuing Ops | $173M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $184M |
| Net Income Deductions | -$1M |
| BOTTOM LINE NET INCOME | $186M |
| D&A | $39M |
| EBIT | $225M |
| EBITDA | $265M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $530M |
| Cost of Revenue | $285M |
| GROSS PROFIT | $245M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $17M |
| Other Expenses | $2M |
| Operating Expenses | $19M |
| Cost & Expenses | $304M |
| OPERATING INCOME | $225M |
| Interest Income | $4M |
| Interest Expense | $4M |
| Other Income/Expenses | -$16M |
| INCOME BEFORE TAX | $210M |
| Income Tax Expense | $36M |
| Net Income from Continuing Ops | $173M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $184M |
| Net Income Deductions | -$1M |
| BOTTOM LINE NET INCOME | $186M |
| D&A | $39M |
| EBIT | $225M |
| EBITDA | $265M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $184M |
| Depreciation & Amortization | $39M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$16M |
| Other Non-Cash Items | $7M |
| Change in Working Capital | -$40M |
| OPERATING CASH FLOW | $175M |
| Capital Expenditure | -$67M |
| Acquisitions (Net) | -$3M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$111M |
| NET CASH FROM INVESTING | -$54M |
| Net Debt Issuance | -$21M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $26M |
| NET CASH FROM FINANCING | $6M |
| FREE CASH FLOW | $108M |
| Net Change in Cash | $125M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $535M |
| Short-Term Investments | $41M |
| Net Receivables | $136M |
| Inventory | $516M |
| Other Current Assets | $59M |
| TOTAL CURRENT ASSETS | $1.3B |
| PP&E (Net) | $4.1B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $5M |
| Other Non-Current Assets | $669M |
| TOTAL NON-CURRENT ASSETS | $4.8B |
| TOTAL ASSETS | $6.1B |
| Account Payables | $41M |
| Short-Term Debt | $250M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $328M |
| TOTAL CURRENT LIABILITIES | $618M |
| Long-Term Debt | $69M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $287M |
| Other Non-Current Liabilities | $710M |
| TOTAL NON-CURRENT LIABILITIES | $1.2B |
| TOTAL LIABILITIES | $1.8B |
| Common Stock | $3.0B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $509M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.5B |
| Minority Interest | $805M |
| TOTAL EQUITY | $4.3B |
| TOTAL LIABILITIES & EQUITY | $6.1B |
| Total Debt | $412M |
| Net Debt | -$123M |
